Congenital erythropoietic porphyria affecting two brothers

British Journal of Dermatology

Volumn 141, Issue 3, 1999, Pages 547-550

  Saval, A Herrera ^a   Tirado, A Moruno ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL INFANTA ELENA   (Spain)

Author keywords

Congenital erythropoietic porphyria; Gunther's disease; Mutation detection; Uroporphyrinogen III cosynthase

Indexed keywords

UROPORPHYRINOGEN III SYNTHASE;

ARTICLE; BLISTER; CASE REPORT; CONGENITAL ERYTHROPOIETIC PORPHYRIA; HEMOLYSIS; HUMAN; HYPERTRICHOSIS; HYPOPIGMENTATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN ULCER;

CHILD, PRESCHOOL; ERYTHROCYTES; HAND DERMATOSES; HUMANS; INFANT; MALE; MUTATION, MISSENSE; PORPHYRIA, ERYTHROPOIETIC; UROPORPHYRINOGEN III SYNTHETASE;

EID: 0032881098     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.03057.x     Document Type: Article

References (24)

1. Romeo G, Levin EY. Uroporphyrinogen III cosynthase in human congenital erythropoietic porphyria. Proc Natl Acad Sci USA 1969; 63: 856-63.
2. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: The Metabolic and Molecular Basis of Inherited Diseases (Scriver CR, Beaudet AL, Shy WS, Valle E, eds), New York; McGraw-Hill, 1995; 2103-59.
3. Fritsch C, Bolsen K, Ruzicka T, Goerz G. Congenital erythropoietic porphyria. J Am Acad Dermatol 1997; 36: 594-610.
4. Astrin KH, Warner CA, Yoo HW et al. Regional assignment of the human uroporphyrinogen III synthase (UROS) gene to chromosome 10q25.2 → q26.3. Hum Genet 1991; 87: 18-22.
5. Deybach JC, de Verneuil H, Boulechfar S et al. Point mutations in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria (Günther's disease). Blood 1990; 75: 1763-5.
6. Xu W, Warner CA, Desnick RJ. Congenital erythropoietic porphyria: identification and expression of 10 mutations in the uroporphyrinogen III synthase gene. J Clin Invest 1995; 95: 905-12.
7. Fontanellas A, Bensidhoum M, Enriquez de Salamanca R et al. A systematic analysis of the mutations of the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria. Eur J Hum Genet 1996; 4: 274-82.
8. Boulechfar S, Da Silva V, Deybach JC et al. Heterogeneity of mutations in uroporphyrinogen III synthase gene in congenital erythropoietic porphyria. Hum Genet 1992; 88: 320-4.
9. May E, Bloch-Michel H, Tournier P. Porphyric familiale (maladie de Günther) dans la même fratrie. Bull Soc Med Hop Paris 1948; 64: 340-5.
10. Bolgert M, Ganivet J, LeSourd L. Trois cas de porphyric cutanée congénitale (maladie de Günther) dans la même fratrie. Bull Soc Fr Dermatol Syphiligr 1952; 59: 233-42.
11. Darocha T, Weremowicz J, Gregor A. Family study in congenital erythropoietic porphyria. S Afr Med J 1971; 7: 231-7.
12. Townsend-Coles WF, Barnes HD. Erythropoietic (congenital) porphyria: two cases in Sudanese siblings. Lancet 1957; ii: 271-3.
13. Boudghene-Stambouli O, Merad-Boudia A, Ould-Amrouche N et al. La porphyrie érythropoïétique congénitale: observation familiale. Ann Dermatol Venereol 1992; 119: 365-8.
14. Tsai SF, Bishop DF, Desnick RJ. Human uroporphyrinogen III synthase, molecular cloning, nucleotide sequence and expression of a full-length cDNA. Proc Natl Acad Sci USA 1988; 85: 7049-53.
15. Mazurier F, Moreau-Gaudry F, Salesse S et al. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria. J Inherit Metab Dis 1997; 20: 247-57.
16. de Verneuil H, Moreau-Gaudry F, Ged C et al. Congenital erythropoietic porphyria. À propos of a fatal case in the neonatal period due to acute hemolysis with hepatic failure. Arch Pediatr 1995; 2: 755-61.
17. Piomelli S, Poh-Fitzpatrick MB, Seaman C et al. Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high level transfusions. N Engl J Med 1986; 314: 1029-31.
18. Huang J-L, Zaider E, Roth P et al. Congenital erythropoietic porphyria: clinical, biochemical, and enzymatic profile of a severely affected infant. J Am Acad Dermatol 1996; 34: 924-7.
19. Rank JM, Straka JG, Weimer MK et al. Hematin therapy in late onset congenital erythropoietic porphyria. Br J Haematol 1990; 75: 617-22.
20. Guarini L, Piomelli S, Poh-Fitzpatrick MB. Hydroxyurea in congenital erythropoietic porphyria. N Engl J Med 1994; 330: 1091-2.
21. Hift RJ, Meissner PN, Kirsch RE. The effect of oral activated charcoal on the course of congenital erythropoietic porphyria. Br J Dermatol 1993; 129: 14-17.
22. Thomas C, Ged C, Nordmann Y et al. Correction of congenital erythropoietic porphyria by bone marrow transplantation. J Pediatr 1996; 129: 453-6.
23. Zix-Kieffer I, Langer B, Eyer D et al. Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther's disease). Bone Marrow Transplant 1996; 18: 217-20.
24. de Verneuil H, Moreau-Gaudry F, Ged C. A model of congenital erythropoietic porphyria for gene transfer in hematopoietic cells. Transfus Clin Biol 1997; 4: 263-6.